mRNA MRK 1777
Latest Information Update: 02 Feb 2017
At a glance
- Originator Merck & Co; Moderna Therapeutics
- Developer Moderna Therapeutics
- Class Antivirals; RNA vaccines; Vaccines
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Infections